Induction of Le(Y) antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells

被引:0
|
作者
Yamada, T
Ohwada, S
Saitoh, F
Adachi, M
Morishita, Y
Hozumi, M
机构
[1] GUNMA UNIV,SCH MED,DEPT SURG 2,MAEBASHI,GUMMA 371,JAPAN
[2] JAPAN IMMUNORES LAB CO LTD,TAKASAKI,GUMMA 370,JAPAN
[3] SAITAMA CANC CTR,RES INST,INA,SAITAMA 362,JAPAN
关键词
5-aza-2'-deoxycytidine; pancreatic cancer; cell cycle; Le(Y) antigen; apoptosis differentiation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the effect of 5-aza-2'-deoxycytidine (ADC) (a specific inhibitor of DNA methylation) on differentiation, Lewis(y) (Le(y)) antigen expression, and DNA fragmentation (a biochemical marker of apoptosis) in human pancreatic cancer MIA PaCa-2 cells. ADC markedly inhibited the growth of MIA PaCa-2 cells. Flow cytometric analysis showed that ADC suppressed the cell population in the G(1) phase, but enhanced it in the G(2)/M phase. On the other hand, several markers of cell differentiation including morphological and biochemical alterations were distinctly induced in cells treated with ADC. Morphologically, the cells were enlarged and thinner than the untreated control cells, and intracellular alkaline phosphatase (ALP) activity was markedly increased. Additionally, biochemical markers of apoptosis including DNA fragmentation and Le(y) antigen expression were induced in association with the appearance of morphological and biochemical markers of differentiation (ALP). These results suggest that the hypomethylation of DNA is involved in the molecular mechanism of growth inhibition, induction of apoptosis, and differentiation in human pancreatic cancer MIA PaCa-2 cells.
引用
收藏
页码:735 / 740
页数:6
相关论文
共 50 条
  • [31] NAG-1 expression and apoptosis induction by trichostatin A or 5-aza-2′-deoxycytidine in endometrial cells from endometriosis patients
    Jung, Y.
    Cho, S.
    Choi, Y.
    Lee, B.
    Seo, S.
    HUMAN REPRODUCTION, 2012, 27
  • [32] 5-Aza-2′-Deoxycytidine Improves the Sensitivity of Endometrial Cancer Cells to Progesterone Therapy
    Hu, Qian
    Yu, Li
    Chen, Rui
    Wang, Yan-ling
    Ji, Lei
    Zhang, Yan
    Xie, Ya
    Liao, Qin-ping
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (06) : 951 - 959
  • [33] De novo induction of a cancer/testis antigen by 5-aza-2′-deoxycytidine augments adoptive immunotherapy in a murine tumor model
    Guo, ZS
    Hong, JA
    Irvine, KR
    Chen, GA
    Spiess, PJ
    Liu, Y
    Zeng, G
    Wunderlich, JR
    Nguyen, DM
    Restifo, NP
    Schrump, DS
    CANCER RESEARCH, 2006, 66 (02) : 1105 - 1113
  • [34] Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-aza-2′-deoxycytidine sensitizes human breast cancer cells to adriamycin
    Xu, Jing
    Zhou, Jun-Ying
    Tainsky, Michael A.
    Wu, Gen Sheng
    CANCER RESEARCH, 2007, 67 (03) : 1203 - 1211
  • [35] CYTOTOXIC ACTIVITY AND MECHANISM OF ACTION OF 5-AZA-2'-DEOXYCYTIDINE IN HUMAN CML CELLS
    LIMONTA, M
    COLOMBO, T
    DAMIA, G
    CATAPANO, CV
    CONTER, V
    GERVASONI, M
    MASERA, G
    LISO, V
    SPECCHIA, G
    GIUDICI, G
    DINCALCI, M
    LEUKEMIA RESEARCH, 1993, 17 (11) : 977 - 982
  • [36] INDUCTION OF DIFFERENTIATION AND INHIBITION OF DNA METHYLATION IN HL-60 MYELOID LEUKEMIC-CELLS BY 5-AZA-2'-DEOXYCYTIDINE
    MOMPARLER, RL
    BOUCHARD, J
    SAMSON, J
    LEUKEMIA RESEARCH, 1985, 9 (11) : 1361 - 1366
  • [37] 5-AZA-2'-DEOXYCYTIDINE IN ADVANCED OR RECURRENT CANCER OF THE UTERINE CERVIX
    VERMORKEN, JB
    TUMOLO, S
    ROOZENDAAL, KJ
    GUASTALLA, JP
    SPLINTER, TAW
    RENARD, J
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (02) : 216 - 217
  • [38] STEPWISE INDUCTION OF DIFFERENTIATION OF THE U-937 MONOBLASTIC CELL-LINE BY 5-AZA-2'-DEOXYCYTIDINE
    ATTADIA, V
    PINTO, A
    COLOMBATTI, A
    EXPERIMENTAL HEMATOLOGY, 1988, 16 (06) : 474 - 474
  • [39] Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway
    Edoardo Missiaglia
    Massimo Donadelli
    Marta Palmieri
    Tatjana Crnogorac-Jurcevic
    Aldo Scarpa
    Nicholas R Lemoine
    Oncogene, 2005, 24 : 199 - 211
  • [40] Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2′-deoxycytidine treatment is associated with activation of the interferon signalling pathway
    Missiaglia, E
    Donadelli, M
    Palmieri, M
    Crnogorac-Jurcevic, T
    Scarpa, A
    Lemoine, NR
    ONCOGENE, 2005, 24 (01) : 199 - 211